Tapewire

Nasdaq · USD

IOVA

IOVANCE BIOTHERAPEUTICS, INC.

Export transactions ↓
Tapewire entity
2090
SEC CIK
0001425205
Parsed reports
251

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 30, 2026 Filed Oct 3, 2026 01:01 UTC
Berkowitz NoahChief Medical Officer
GrantPerformance Stock Units · Derivative 135,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-113342 · tm2626734-2_4seq1.xml · derivative · entry 3

Berkowitz Noah · CIK 0001369900 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,000

Underlying: Common stock · 135,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each performance stock unit ("PSU") converts into one share of the Issuer's common stock.

F4 · shares: Up to 135,000 shares of the Issuer's common stock underlying the PSUs may be earned subject to achievement of certain regulatory milestones.

F5 · derivative.exercise_date: Such earned PSUs shall vest on the date that the Issuer publicly discloses on a Form 8-K with the U.S. Securities and Exchange Commission its receipt of certain regulatory milestones.

F5 · derivative.expiration_date: Such earned PSUs shall vest on the date that the Issuer publicly discloses on a Form 8-K with the U.S. Securities and Exchange Commission its receipt of certain regulatory milestones.

Read SEC document
September 30, 2026 Filed Oct 3, 2026 01:01 UTC
Berkowitz NoahChief Medical Officer
GrantRestricted Stock Units · Derivative 180,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-113342 · tm2626734-2_4seq1.xml · derivative · entry 2

Berkowitz Noah · CIK 0001369900 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,000

Underlying: Common stock · 180,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F1 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.

F1 · derivative.expiration_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.

Read SEC document
September 30, 2026 Filed Oct 3, 2026 01:01 UTC
Berkowitz NoahChief Medical Officer
GrantStock Options (Right to Buy) · Derivative 135,000 $0.00 Strike: $14.82 $0.00
Disclosure

SEC source: 0001104659-26-113342 · tm2626734-2_4seq1.xml · derivative · entry 1

Berkowitz Noah · CIK 0001369900 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,000

Underlying: Common stock · 135,000 shares

Expires 2036-09-30

F1 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the restricted stock units ("RSUs") and options are each exercisable as follows: (i) RSUs and options for the purchase of one-third of such shares shall vest on the one-year anniversary of the date of grant; and (ii) the remaining RSUs and options shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 21:01 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Exercise / conversionRestricted Stock Units · Derivative 15,626 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-106752 · tm2625111-3_4seq1.xml · derivative · entry 3

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,756

Underlying: Common stock · 15,626 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 21:01 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Tax withholdingCommon Stock 6,638 $8.70 $57,750.60
Disclosure

SEC source: 0001104659-26-106752 · tm2625111-3_4seq1.xml · nonDerivative · entry 2

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 595,447

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 21:01 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Exercise / conversionCommon Stock 15,626 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-106752 · tm2625111-3_4seq1.xml · nonDerivative · entry 1

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 602,085

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 21:00 UTC
BILINSKY IGORChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 7,813 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-106750 · tm2625111-2_4seq1.xml · derivative · entry 3

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,878

Underlying: Common stock · 7,813 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 21:00 UTC
BILINSKY IGORChief Operating Officer
Tax withholdingCommon Stock 3,976 $8.70 $34,591.20
Disclosure

SEC source: 0001104659-26-106750 · tm2625111-2_4seq1.xml · nonDerivative · entry 2

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,074

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 21:00 UTC
BILINSKY IGORChief Operating Officer
Exercise / conversionCommon Stock 7,813 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-106750 · tm2625111-2_4seq1.xml · nonDerivative · entry 1

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,050

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 21:00 UTC
Puri Raj K.Chief Regulatory Officer
Exercise / conversionRestricted Stock Units · Derivative 9,766 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-106748 · tm2625111-1_4seq1.xml · derivative · entry 3

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,599

Underlying: Common stock · 9,766 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 21:00 UTC
Puri Raj K.Chief Regulatory Officer
Tax withholdingCommon Stock 4,478 $8.70 $38,958.60
Disclosure

SEC source: 0001104659-26-106748 · tm2625111-1_4seq1.xml · nonDerivative · entry 2

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 256,364

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 21:00 UTC
Puri Raj K.Chief Regulatory Officer
Exercise / conversionCommon Stock 9,766 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-106748 · tm2625111-1_4seq1.xml · nonDerivative · entry 1

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 260,842

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 21:02 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Exercise / conversionRestricted Stock Units · Derivative 41,669 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-105101 · tm2624648-3_4seq1.xml · derivative · entry 3

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 83,338

Underlying: Common stock · 41,669 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 21:02 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Tax withholdingCommon Stock 17,702 $8.28 $146,572.56
Disclosure

SEC source: 0001104659-26-105101 · tm2624648-3_4seq1.xml · nonDerivative · entry 2

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 586,459

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 21:02 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Exercise / conversionCommon Stock 41,669 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-105101 · tm2624648-3_4seq1.xml · nonDerivative · entry 1

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 604,161

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 21:02 UTC
Puri Raj K.Chief Regulatory Officer
Exercise / conversionRestricted Stock Units · Derivative 5,470 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-105100 · tm2624648-2_4seq1.xml · derivative · entry 3

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,939

Underlying: Common stock · 5,470 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 21:02 UTC
Puri Raj K.Chief Regulatory Officer
Tax withholdingCommon Stock 2,508 $8.28 $20,766.24
Disclosure

SEC source: 0001104659-26-105100 · tm2624648-2_4seq1.xml · nonDerivative · entry 2

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 251,076

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 21:02 UTC
Puri Raj K.Chief Regulatory Officer
Exercise / conversionCommon Stock 5,470 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-105100 · tm2624648-2_4seq1.xml · nonDerivative · entry 1

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 253,584

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 21:00 UTC
BILINSKY IGORChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 8,789 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-105099 · tm2624648-1_4seq1.xml · derivative · entry 3

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,580

Underlying: Common stock · 8,789 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 21:00 UTC
BILINSKY IGORChief Operating Officer
Tax withholdingCommon Stock 4,472 $8.28 $37,028.16
Disclosure

SEC source: 0001104659-26-105099 · tm2624648-1_4seq1.xml · nonDerivative · entry 2

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,237

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 21:00 UTC
BILINSKY IGORChief Operating Officer
Exercise / conversionCommon Stock 8,789 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-105099 · tm2624648-1_4seq1.xml · nonDerivative · entry 1

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 142,709

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
August 10, 2026 Filed Aug 12, 2026 21:30 UTC
Kirby Daniel GordonChief Commercial Officer
Exercise / conversionRestricted Stock Units · Derivative 10,001 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-095040 · tm2622903-1_4seq1.xml · derivative · entry 3

Kirby Daniel Gordon · CIK 0002055001 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,003

Underlying: Common Stock · 10,001 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on February 10, 2025, but does not include any other RSUs held by such Reporting Person.

Read SEC document
August 10, 2026 Filed Aug 12, 2026 21:30 UTC
Kirby Daniel GordonChief Commercial Officer
Tax withholdingCommon Stock 2,436 $6.40 $15,590.40
Disclosure

SEC source: 0001104659-26-095040 · tm2622903-1_4seq1.xml · nonDerivative · entry 2

Kirby Daniel Gordon · CIK 0002055001 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,511

F2 · date: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
August 10, 2026 Filed Aug 12, 2026 21:30 UTC
Kirby Daniel GordonChief Commercial Officer
Exercise / conversionCommon Stock 10,001 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-095040 · tm2622903-1_4seq1.xml · nonDerivative · entry 1

Kirby Daniel Gordon · CIK 0002055001 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,947

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
August 06, 2026 Filed Aug 10, 2026 21:30 UTC
Roche Corleen M.Chief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 49,995 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-093482 · tm2622610-1_4seq1.xml · derivative · entry 3

Roche Corleen M. · CIK 0001857905 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,005

Underlying: Common Stock · 49,995 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on August 6, 2025, but does not include any other RSUs held by such Reporting Person.

Read SEC document
August 06, 2026 Filed Aug 10, 2026 21:30 UTC
Roche Corleen M.Chief Financial Officer
Tax withholdingCommon Stock 21,238 $6.21 $131,887.98
Disclosure

SEC source: 0001104659-26-093482 · tm2622610-1_4seq1.xml · nonDerivative · entry 2

Roche Corleen M. · CIK 0001857905 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,757

F2 · date: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
August 06, 2026 Filed Aug 10, 2026 21:30 UTC
Roche Corleen M.Chief Financial Officer
Exercise / conversionCommon Stock 49,995 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-093482 · tm2622610-1_4seq1.xml · nonDerivative · entry 1

Roche Corleen M. · CIK 0001857905 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,995

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 21:15 UTC
Puri Raj K.Chief Regulatory Officer
GrantRestricted Stock Units · Derivative 15,000 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-075854 · tm2618145-1_4seq1.xml · derivative · entry 1

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common stock · 15,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

F2 · derivative.exercise_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.

F2 · derivative.expiration_date: Provided the Reporting Person is still employed with the Issuer on the following dates, the RSUs shall vest over three years, with (i) one-third of the RSUs vesting on the one-year anniversary of the date of grant and (ii) the remaining RSUs shall vest in eight equal quarterly installments over the next two years, commencing with the first quarter following the first anniversary of the date of grant.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 21:17 UTC GrantDeferred Restricted Stock Unit · Derivative 90,316 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-075863 · tm2618145-5_4seq1.xml · derivative · entry 1

WEISER MICHAEL · CIK 0001221449 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,316

Underlying: Common Stock · 90,316 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended).

F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 21:15 UTC GrantDeferred Restricted Stock Unit · Derivative 90,316 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-075856 · tm2618145-2_4seq1.xml · derivative · entry 1

Maynard Ryan D · CIK 0001363984 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,316

Underlying: Common Stock · 90,316 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended).

F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 21:16 UTC GrantDeferred Restricted Stock Unit · Derivative 180,632 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-075861 · tm2618145-4_4seq1.xml · derivative · entry 1

Dukes Iain D. · CIK 0001681955 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,632

Underlying: Common Stock · 180,632 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended).

F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

Read SEC document
June 16, 2026 Filed Jun 18, 2026 21:16 UTC GrantDeferred Restricted Stock Unit · Derivative 90,316 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-075858 · tm2618145-3_4seq1.xml · derivative · entry 1

Countouriotis Athena · CIK 0001571469 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,316

Underlying: Common Stock · 90,316 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended).

F2 · derivative.exercise_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

F2 · derivative.expiration_date: Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (ii) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reporting Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 21:00 UTC
Puri Raj K.Chief Regulatory Officer
Exercise / conversionRestricted Stock Units · Derivative 9,766 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-071895 · tm2617137-2_4seq1.xml · derivative · entry 3

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,365

Underlying: Common stock · 9,766 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 21:00 UTC
Puri Raj K.Chief Regulatory Officer
Tax withholdingCommon Stock 3,843 $4.23 $16,255.89
Disclosure

SEC source: 0001104659-26-071895 · tm2617137-2_4seq1.xml · nonDerivative · entry 2

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 248,114

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 21:00 UTC
Puri Raj K.Chief Regulatory Officer
Exercise / conversionCommon Stock 9,766 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-071895 · tm2617137-2_4seq1.xml · nonDerivative · entry 1

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 251,957

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 17:01 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 7,813 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-071897 · tm2617137-3_4seq1.xml · derivative · entry 3

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,691

Underlying: Common stock · 7,813 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 17:01 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Tax withholdingCommon Stock 3,976 $4.23 $16,818.48
Disclosure

SEC source: 0001104659-26-071897 · tm2617137-3_4seq1.xml · nonDerivative · entry 2

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,111

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 17:01 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Exercise / conversionCommon Stock 7,813 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-071897 · tm2617137-3_4seq1.xml · nonDerivative · entry 1

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,087

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 17:03 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Exercise / conversionRestricted Stock Units · Derivative 15,625 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-071899 · tm2617137-4_4seq1.xml · derivative · entry 3

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,382

Underlying: Common stock · 15,625 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 17:03 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Tax withholdingCommon Stock 6,638 $4.23 $28,078.74
Disclosure

SEC source: 0001104659-26-071899 · tm2617137-4_4seq1.xml · nonDerivative · entry 2

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 562,492

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 17:03 UTC
Vogt Frederick GDirector · Interim CEO & General Counsel
Exercise / conversionCommon Stock 15,625 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-071899 · tm2617137-4_4seq1.xml · nonDerivative · entry 1

Vogt Frederick G · CIK 0001719678 · Director · Interim CEO & General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 569,130

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 21:00 UTC
BILINSKY IGORChief Operating Officer
Exercise / conversionRestricted Stock Units · Derivative 7,813 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-071891 · tm2617137-1_4seq1.xml · derivative · entry 3

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,691

Underlying: Common stock · 7,813 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 21:00 UTC
BILINSKY IGORChief Operating Officer
Tax withholdingCommon Stock 3,976 $4.23 $16,818.48
Disclosure

SEC source: 0001104659-26-071891 · tm2617137-1_4seq1.xml · nonDerivative · entry 2

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 133,920

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
June 05, 2026 Filed Jun 9, 2026 21:00 UTC
BILINSKY IGORChief Operating Officer
Exercise / conversionCommon Stock 7,813 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-071891 · tm2617137-1_4seq1.xml · nonDerivative · entry 1

BILINSKY IGOR · CIK 0001594604 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 137,896

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 21:01 UTC
Puri Raj K.Chief Regulatory Officer
Exercise / conversionRestricted Stock Units · Derivative 5,469 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-070153 · tm2616710-3_4seq1.xml · derivative · entry 3

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,409

Underlying: Common stock · 5,469 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 21:01 UTC
Puri Raj K.Chief Regulatory Officer
Tax withholdingCommon Stock 2,508 $3.96 $9,931.68
Disclosure

SEC source: 0001104659-26-070153 · tm2616710-3_4seq1.xml · nonDerivative · entry 2

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 242,191

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 21:01 UTC
Puri Raj K.Chief Regulatory Officer
Exercise / conversionCommon Stock 5,469 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-070153 · tm2616710-3_4seq1.xml · nonDerivative · entry 1

Puri Raj K. · CIK 0002046483 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 244,699

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 21:00 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 8,790 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-070152 · tm2616710-2_4seq1.xml · derivative · entry 3

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,369

Underlying: Common stock · 8,790 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock.

F5 · derivative.exercise_date: The remaining RSUs will vest in equal quarterly installments.

F5 · derivative.expiration_date: The remaining RSUs will vest in equal quarterly installments.

F6 · balance_after: Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 21:00 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Tax withholdingCommon Stock 4,473 $3.96 $17,713.08
Disclosure

SEC source: 0001104659-26-070152 · tm2616710-2_4seq1.xml · nonDerivative · entry 2

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,274

F2 · security: Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.

F3 · balance_after: Represents the common stock remaining after deducting the common stock withheld for taxes.

Read SEC document
June 01, 2026 Filed Jun 3, 2026 21:00 UTC
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer
Exercise / conversionCommon Stock 8,790 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-070152 · tm2616710-2_4seq1.xml · nonDerivative · entry 1

GRAF FINCKENSTEIN FRIEDRICH · CIK 0001782981 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 140,747

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.